Australia's most trusted
source of pharma news
Saturday, 27 July 2024
Posted 13 May 2024 AM
AstraZeneca's hyped breast cancer drug Truqap has reached Australia ahead of Europe after being reviewed under Project Orbis.
The initiative of the FDA Oncology Center of Excellence provides a framework for concurrent submission and review of oncology drugs among international partners.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.